Detlev Platen - Dr Ing Head Board
DRPRF Stock | USD 59.39 4.01 6.32% |
Insider
Detlev Platen is Head Board of Dr Ing hc
Age | 59 |
Phone | 49 711 911 0 |
Web | https://www.porsche.com/international |
Similar Executives
Showing other executives | INSIDER Age | ||
Albrecht Reimold | Dr Ing hc | 62 | |
Manfred Doss | Porsche Automobil Holding | 65 | |
Hannes Ruoff | Porsche Automobil Holding | N/A | |
Jens Brucker | Porsche Automobil Holding | N/A | |
Britta Seeger | Mercedes Benz Group AG | 54 | |
Hubertus Troska | Mercedes Benz Group AG | 63 | |
Michael Steiner | Dr Ing hc | 59 | |
Oliver Blume | Dr Ing hc | 55 | |
Lutz Meschke | Porsche Automobil Holding | 57 | |
Markus Schafer | Mercedes Benz Group AG | 58 | |
Kapila Perrera | Porsche Automobil Holding | 64 | |
Renata Brungger | Mercedes Benz Group AG | 62 | |
Thomas Laubert | Mercedes Benz Group AG | 50 | |
Albrecht Bamler | Porsche Automobil Holding | 65 | |
Jorg Burzer | Mercedes Benz Group AG | 53 | |
Sabine Kohleisen | Mercedes Benz Group AG | 59 | |
Barbara Frenkel | Dr Ing hc | 60 | |
Hans MSc | Porsche Automobil Holding | 72 | |
George Wills | Porsche Automobil Holding | N/A | |
Ola Kallenius | Mercedes Benz Group AG | 54 | |
Johannes Lattwein | Porsche Automobil Holding | N/A |
Dr Ing hc Leadership Team
Elected by the shareholders, the Dr Ing's board of directors comprises two types of representatives: Dr Ing inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DRPRF. The board's role is to monitor Dr Ing's management team and ensure that shareholders' interests are well served. Dr Ing's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dr Ing's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lutz Meschke, CFO Board | ||
Michael Steiner, Member RD | ||
Albrecht Reimold, Member Logistics | ||
Detlev Platen, Head Board | ||
Barbara Frenkel, Member Procurement | ||
Andreas Haffner, Member Affairs | ||
Oliver Blume, Chairman CEO |
DRPRF Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Dr Ing a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Profit Margin | 0.14 % | |||
Operating Margin | 0.20 % | |||
Shares Owned By Insiders | 7.00 % | |||
Shares Owned By Institutions | 13.52 % | |||
Revenue | 36.76 B | |||
Gross Profit | 8.99 B | |||
EBITDA | 9.38 B | |||
Net Income | 4.03 B | |||
Cash And Equivalents | 5.87 B | |||
Cash Per Share | 64.53 X |
Currently Active Assets on Macroaxis
Other Information on Investing in DRPRF Pink Sheet
Dr Ing financial ratios help investors to determine whether DRPRF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DRPRF with respect to the benefits of owning Dr Ing security.